Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)

China · Delayed Price · Currency is CNY

21.06

-0.17 (-0.80%)

Oct 16, 2026, 3:00 PM CST

Market Cap	11.94B -6.9%
Revenue (ttm)	3.90B +5.6%
Net Income	780.21M -0.5%
EPS	1.37 -0.9%
Shares Out	567.12M
PE Ratio	15.32
Forward PE	14.33
Dividend	1.10 (5.22%)
Ex-Dividend Date	Jun 11, 2026

Volume	12,833,264
Open	21.14
Previous Close	21.23
Day's Range	20.77 - 21.49
52-Week Range	18.51 - 23.65
Beta	-0.02
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About SHA:600285

Henan Lingrui Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China. It operates through Medical and Healthcare Division; and Others segments. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, and tinctures, etc. for various indications, including orthopedic, cardiovascular, cerebrovascular, dermatology, pediatrics, respiratory, nutritional supplements, and anesthesiology. Its products include Tongluoqutong... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1992

Employees 2,789

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600285

Full Company Profile

Financial Performance

In 2025, SHA:600285's revenue was 3.85 billion, an increase of 10.07% compared to the previous year's 3.50 billion. Earnings were 759.50 million, an increase of 5.11%.

Financial Statements